Testing a diabetes drug to help stop meth use
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medication called 'Glutide' (a GLP-1 agonist, similar to drugs used for diabetes) can help people who want to stop or cut down on methamphetamine. It's for those with moderate to severe meth use disorder who have used meth on at least 15 of the past 30 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have used meth on at least 15 of the past 30 days and test positive for meth in a urine test.
- You must want to stop or reduce your meth use.
- Your BMI must be 25 or higher (overweight).
- You cannot be pregnant, plan to become pregnant, or breastfeed, and must agree to use effective birth control if applicable.
- You must not have certain health conditions like diabetes, heart failure, pancreatitis, or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide, a medication that affects appetite and cravings, can help people reduce or stop using methamphetamine. It may be a new option for those struggling with moderate to severe methamphetamine use disorder.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.
This study tests whether a once-weekly injection of semaglutide (a GLP-1 receptor agonist) can reduce opioid use in people who are already on buprenorphine or methadone but still using opioids. It lasts about 19 weeks.
This trial tests if semaglutide, a medicine sometimes used for weight management, can help people recovering from opioid use disorder stay on track. It is for adults who have already started buprenorphine treatment and are ready to take part in a research study.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
Hear when a new Methamphetamine-dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.